(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

SIALILTRANSFERASES PARA SÍNTESE IN VIVO DE 3'SL

ArquivadaInvention Patent

Application data

Invention Patent SIALILTRANSFERASES PARA SÍNTESE IN VIVO DE 3'SL de DSM IP ASSETS B.V. — IPC C12N 1/21
Invention Patent SIALILTRANSFERASES PARA SÍNTESE IN VIVO DE 3'SL de DSM IP ASSETS B.V. — IPC C12N 1/21. Drawing published by the INPI in the Industrial Property Gazette.

Number

102023003679

Type

Invention Patent

Filing

02/28/2023

Publication

09/12/2023

Progress at the INPI

  1. Filing02/28/23
  2. Publication09/12/23
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 02/28/2023 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 05/26/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

DSM IP ASSETS B.V.

NL

See this company's full portfolio

Inventors

M. P. (pessoa física)

DK

Technical data

Priority claims

DK

PA202270077 · 03/02/2022

Abstract

SIALILTRANSFERASES PARA SÍNTESE IN VIVO DE 3'SL. A presente divulgação se refere à produção de Oligossacarídeos do Leite Humano (HMOs) sialilados, em particular à produção biossintética de 3'-sialilactose (3'SL) e a células geneticamente modificadas e métodos adequados para a referida produção.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

05/26/2026

RPI 2890

Arquivamento - Art. 33 da LPI

#11.1

03/10/2026

RPI 2879

Publicação do pedido de patente

#3.1

09/12/2023

RPI 2749

Pedido de patente depositado

#2.1

03/28/2023

RPI 2725

Requerimento de pedido de patente

#2.10

Número de Protocolo '870230016853' em 28/02/2023 09:42 (WB)

03/14/2023

RPI 2723

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.